Danielle van Reijn-Baggen

Chapter 3 70 Study Design/N Population/ Mean age SD/ range) Interventions/Duration Outcome Measures (muscle tone/ function, pain, sexual function, pelvic floor symptoms, QoL, PPE) Results ICPI Pre-to post-treatment: IC/PBS (p<.01) CP/CPPS (p<.01) PFPT vs control: IC/PBS (p<.05) CP/CPPS: ns NIH-CPSI total NIH-urinary NIH- QoL Pre-to post-treatment: CP/CPPS (p<.001) PFPT vs control: ns Pre-to post-treatment: CP/CPPS (p<.001) PFPT vs control (p<.01) Pre-to post-treatment: CP/CPPS (p<.05) PFPT vs control: ns Likert urinary urgency score Likert urinary frequency score Pre-to post-treatment: IC/PBS (p<.01) PFPT vs control: ns Pre-to post-treatment: IC/PBS (p<.05) PFPT vs control: ns Table 2. Continued

RkJQdWJsaXNoZXIy MTk4NDMw